CSL.AX (CSL.AX)

$68.3B
Market Cap
15.7
P/E Ratio
0.21
Beta
3.03%
Dividend Yield
Piotroski 6/9Altman Z 3.9 SafeBeneish M -2.40 CleanROIC−WACC +1.9%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 3.9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of CSL.AX demonstrates a modest but positive spread between return on invested capital and the weighted average cost of capital, indicating that the firm generates value above its required hurdle rate. This operational quality is underpinned by robust profitability metrics, where a 19.5% net margin and 51.5% gross margin suggest strong pricing power or high barriers to entry within its specific business lines. The DuPont decomposition points toward margin-driven returns rather than leverage-fueled expansion, as the high margins are not offset by excessive financial risk. Creditworthiness appears stable with an Altman Z-Score of 3.9, placing the firm in a safe zone regarding bankruptcy probability, while a Beneish M-Score of -2.40 signals low likelihood of earnings manipulation and reinforces the integrity of reported fundamentals.

Valuation metrics present a divergence between current multiples and historical norms, with the stock trading at a P/E ratio of 15.7x that requires contextualization against its own long-term average and sector peers to determine if it is undervalued or fairly priced relative to growth expectations. The market appears to be pricing in moderate revenue expansion, assuming a compound annual growth rate consistent with the observed 5.0% year-over-year increase, though this trajectory may limit upside potential compared to higher-growth sectors unless margin compression occurs. A discounted cash flow analysis would likely hinge on whether future free cash flows can sustainably exceed the current ROIC-WACC spread of +1.9%, as any deviation could materially impact implied fair value and necessitate a re-rating of the equity price.

The fundamental profile suggests a mature business with stable earnings quality, yet the modest revenue growth rate introduces a ceiling on multiple expansion unless operational leverage improves or market share gains accelerate. Investors must weigh the safety provided by strong margins and low manipulation risk against the opportunity cost of slower top-line expansion in an environment that may reward higher velocity companies more aggressively.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
3.9
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.40
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

51.5%
Gross Margin
19.5%
Net Margin
9.4%
ROIC
7.5%
WACC
ROIC − WACC Spread: +1.9%— Positive spread.
+5.0%
Revenue Growth (YoY)
+13.6%
Earnings Growth (YoY)

Balance Sheet Health

0.84x
Debt / Equity
2.46x
Current Ratio
10.5x
Interest Coverage
1.4x
Net Debt / EBITDA
5.1B
EBITDA

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

13.1
Forward P/E
PEG Ratio
2.50
Price/Book
1M
Avg Volume
$275.79
52W High
$133.35
52W Low
52W Range Position

Compare CSL.AX to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.